Efficacy and Safety of Zolmitriptan by Sublingual Administration

• Status: Unknown status
• Trial end date: 2019-04-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose is to evaluate the effectiveness and safety profile of zolmitriptan by Sublingual administration for the acute treatment of Cluster headache.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Xijing Hospital
• Treatments: Oxazolidinones; Zolmitriptan

Criteria

Inclusion Criteria:

• Patients older than or equal to 18 years and less than 70 years;

• The diagnosis of cluster headache is made according to The International Classification of Headache Disorders: 3rd edition (beta version)(ICHD-III β);

• Consent form signed by the participant or his/her authorized surrogate.

Exclusion Criteria:

• Patients had primary or secondary headache disorders other than cluster headache;

• Female subjects of childbearing age will be excluded if they were pregnant, lactating or planning a pregnancy in the next year or if they were not using an adequate form of birth control;

• Patients will be excluded if they had significant medical or psychiatric disease;

• Patients will be excluded if they had coronary heart disease or not suitable for the treatment of zolmitriptan.